Anti-HDV-IgM levels as a marker of disease activity and response to pegylated Interferon-? based therapy in hepatitis delta
dc.contributor.author | Wranke, Anika | |
dc.contributor.author | Yurdaydin, Cihan | |
dc.contributor.author | Heidrich, Benjamin | |
dc.contributor.author | Ernst, Stefanie | |
dc.contributor.author | Koch, Armin | |
dc.contributor.author | Serrano, Beatriz Calle | |
dc.contributor.author | Caruntu, Florin A. | |
dc.date.accessioned | 2024-04-24T17:49:58Z | |
dc.date.available | 2024-04-24T17:49:58Z | |
dc.date.issued | 2013 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description | 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases -- NOV 01-05, 2013 -- Washington, DC | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Amer Assoc Study Liver Dis | en_US |
dc.identifier.endpage | 651A | en_US |
dc.identifier.issn | 0270-9139 | |
dc.identifier.issn | 1527-3350 | |
dc.identifier.startpage | 651A | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/23131 | |
dc.identifier.volume | 58 | en_US |
dc.identifier.wos | WOS:000330252203098 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | en_US |
dc.publisher | Wiley-Blackwell | en_US |
dc.relation.ispartof | Hepatology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keyword] | en_US |
dc.title | Anti-HDV-IgM levels as a marker of disease activity and response to pegylated Interferon-? based therapy in hepatitis delta | en_US |
dc.title | Anti-HDV-IgM levels as a marker of disease activity and response to pegylated Interferon-? based therapy in hepatitis delta | |
dc.type | Conference Object | en_US |